Multicenter study on the immunogenicity and safety of two recombinant vaccines against hepatitis B
The immunogenicity and safety of a new recombinant hepatitis B vaccine from the Instituto Butantan (Butang®) were evaluated in a multicenter, double-blind, prospective equivalence study in three centers in Brazil. Engerix B® was the standard vaccine. A total of 3937 subjects were recruited and 2754...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Fundação Oswaldo Cruz (FIOCRUZ)
2004-12-01
|
| Serie: | Memorias do Instituto Oswaldo Cruz |
| Soggetti: | |
| Accesso online: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762004000800014 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|